Latest news with #Claritin
Yahoo
02-06-2025
- Health
- Yahoo
This common over-the-counter drug could be linked to dementia
A commonly-used over-the-counter medication that can provide allergy and cold relief or serve as sleep aids may increase a person's risk of dementia. Antihistamines work to block the chemical histamine, which causes uncomfortable allergy symptoms. However, what kind of antihistamine you're taking can make a big difference to your long-term health. There are two main types of antihistamines on the market: first-generation and second-generation. Physicians say that these 'first-generation' antihistamines are less safe because they more easily cross your blood-brain barrier into the central nervous system, causing drowsiness. The second-generation antihistamines, meanwhile, do not. "People sometimes assume these medications must be harmless because they are sold over the counter, but if you use them too often or for too long, they can mess with your thinking, make you groggy during the day, and possibly lead to long-term problems," Dr. Pamela Tambini, an internal medicine physician and medical director at Engage Wellness, recently told Women's Health. The first-generation antihistamines specifically target a key brain chemical involved in memory that is called acetylcholine. Because of their design, they have a long-term impact on our brain's health. That negative impact has been documented for a few years — but may not be something on your mind when you need relief. Frequent use of these first-generation sleep medications has been tied to an increased risk of the chronic disease in older adults, according to a study published in the Journal of Alzheimer's Disease in 2023. A 2024 study in the Journal of Allergy and Clinical Immunology also said there was some risk associated with second-generation antihistamines, but it was lower. A study published this year in the World Allergy Organization Journal suggests that people should avoid taking Benadryl. Although studies have found an association between the drugs — including Benadryl — and dementia, researchers say it doesn't prove that they do cause the condition, according to Harvard Medical School. However what is known is that the drugs that block acetylcholine, which can cause confusion and increase fall risks in older people. Furthermore, the body's production of acetylcholine dwindles with age. So, blocking that can be an even larger blow to older adults, who are at greater risk for dementia. Notably, many drugs have a stronger effect on older people, who also tend to take more medications. "If you are constantly dampening that system with these medications, your brain does not function as well," said Tambini. "Over time, that can lead to memory issues or even contribute to cognitive decline, particularly if you're already at risk." Instead, doctors recommend people turn to other, newer options, such as Claritin. Although, it is alright to occasionally use an over-the-counter sleep aid. "There are safer, more effective options out there — and talking to your doctor is a great first step in figuring out what's really going on and how to get your sleep back on track,' Tambini said.
The Independent
30-05-2025
- Health
- The Independent
Drugs used to relieve allergies may harm our brains in the long run
Over-the-counter antihistamines, commonly used for allergies, colds, and sleep, may increase the risk of dementia, according to recent studies. First-generation antihistamines, like Benadryl, more easily cross the blood-brain barrier and impact acetylcholine, a key brain chemical for memory, posing a higher risk compared to second-generation options. A 2023 study in the Journal of Alzheimer's Disease linked frequent use of first-generation antihistamines to an increased risk of dementia in older adults. Dr. Pamela Tambini advises caution with over-the-counter antihistamines, noting they can impair thinking and potentially lead to long-term cognitive issues, especially in older adults. Doctors recommend exploring newer antihistamine options like Claritin and consulting with a healthcare provider to determine the safest and most effective treatment.
Yahoo
24-05-2025
- Health
- Yahoo
Enjoying Michigan's lakes could lead to a rash. What to do about swimmer's itch
With temperatures warming up in Michigan, residents might be tempted to take a dip in a lake, but there's a chance you could end up itching later. Swimmer's itch is a skin rash caused by an allergic reaction to microscopic snail parasites that then complete their life cycle in some birds and mammals, according to the Centers for Disease Control and Prevention. People can pick up the parasites if they come in contact with contaminated water — by swimming or spending time in a contaminated freshwater or saltwater lake or public pool. Luckily, most swimmer's itch cases don't require medical attention, according to the CDC, and can be treated with corticosteroid creams and cold compresses, among other things. Here's what to know about swimmer's itch and how to avoid it in Michigan waters if you're considering a chilly swim this Memorial Day weekend: Swimmer's itch is not contagious. Swimmer's itch is a skin rash caused by an allergic reaction to microscopic parasites that infect some birds and mammals, according to the Centers for Disease Control and Prevention. The parasites are released from infected snails into fresh and salt water (such as lakes, ponds, and oceans). While the parasite's preferred host is the specific bird or mammal, if the parasite comes into contact with a swimmer, it burrows into the skin causing an allergic reaction and rash. Swimmer's itch is found throughout the world and is more frequent during summer months. Swimmer's itch is often incorrectly attributed to E. coli exposure, according to the Clean Lakes Alliance. Symptoms of swimmer's itch can include: Tingling, burning or itching of the skin Small reddish pimples Small blisters Swimmer's itch typically clears up on its own within a week. If the itching is severe, your health care provider may recommend prescription-strength lotions or creams, the Mayo Clinic said. Some home treatments may provide relief until it goes away: Apply an over-the-counter corticosteroid cream or an anti-itch lotion, such as those that contain calamine. Take an oral nonprescription antihistamine (Benadryl) or one with loratadine (Alavert, Claritin, others). Avoiding scratching the rash. Cover affected areas with a clean, damp washcloth. Soak in a bath sprinkled with Epsom salts, baking soda or an oatmeal-based bath product (Aveeno, others). Make a paste of baking soda and water, and then apply it to the affected skin. More: Is it safe to swim at the beach? How to check E. coli levels in Michigan More: Memorial Day grilling: Our best recipes, tips and advice for 2025 The EGLE map lists information for beaches in Michigan, including water quality sampling results and beach advisories and closures. The website also includes information on combined or sanitary sewer overflows, which lead to partially treated or untreated sewage being released into rivers and streams. Jalen Williams is a trending reporter at the Detroit Free Press. Contact him at jawilliams1@ This article originally appeared on Detroit Free Press: Swimmer's itch: Causes, treatments for summer annoyance
Yahoo
17-04-2025
- Business
- Yahoo
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
The facility's new space enhances the company's Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement MYERSTOWN, Pa., April 16, 2025--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer's commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community. The ribbon-cutting ceremony was attended by Bayer leaders, employees, elected officials, and members of the local community to commemorate this exciting moment for Bayer and Pennsylvania's Lebanon County. Bayer's Myerstown site has a rich history dating back over 75 years, and it has now grown to become the largest manufacturing site in Bayer's Consumer Health network globally, producing brands such as Bayer® Aspirin, Aleve®, Claritin®, One A Day®, Alka-Seltzer Plus®, Midol®, and more. "Our trusted brands have been helping people live healthier lives for generations. The Myerstown annex will enable us to bring science-backed products to market with more speed and reliability than ever before," stated Dave Tomasi, President of Bayer's Consumer Health division in North America. "The expanded facility will further strengthen our commitment to providing safe, effective and high-quality self-care solutions that our consumers and customers can depend on." Bayer's Myerstown facility is set to advance its production capabilities through the integration of modernized technology and streamlined processes, strengthening its ability to reliably deliver science-driven self-care solutions. The new space is designed to move products more efficiently with eight new product packaging lines and automated systems in logistics. With the expansion, Bayer is increasing its ability to swiftly respond to the evolving needs of its consumers and customers. Bayer's commitment to growth extends beyond infrastructure and technology; it is an investment in the future of health and wellness for consumers across North America and the people of Myerstown. Along with expanding its physical footprint, the company is dedicated to digitally upskilling its workforce to ensure that employees and the local community are equipped with the knowledge needed to navigate the modern manufacturing landscape. Bayer also plans to welcome local high school educators to tour its Myerstown facilities and operations to bring back information and insights to their school districts. "We recognize that the key to sustainable growth lies in our people. That's why we will enable our workforce with the skills needed to adapt to new technologies so they can excel in their careers," said Divakar Amin, Vice President & Site Manager of Myerstown. "We are proud to contribute to the local economy and foster a vibrant workforce made up of many Myerstown locals. Together, we are building a brighter future for Bayer and the communities we serve." As Bayer continues to innovate and empower everyday health, the company remains steadfast in its mission to elevate the quality of life for people around the world through trusted health and nutrition solutions. "Our commitment to credible science and consumer advocacy drives our mission Health for all, Hunger for none," said Michael Sullivan, Senior Vice President of Product Supply for Bayer's Consumer Health division in North America. "We are excited about the positive impact this investment will have as we are paving the way for a healthier future where everyone has access to the products that they need to support their well-being." About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to View source version on Contacts Media Contact: Hannah SchwartzEmail: Cell: 862-783-8442 Sign in to access your portfolio
Yahoo
16-04-2025
- Business
- Yahoo
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
The facility's new space enhances the company's Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement MYERSTOWN, Pa., April 16, 2025--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer's commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community. The ribbon-cutting ceremony was attended by Bayer leaders, employees, elected officials, and members of the local community to commemorate this exciting moment for Bayer and Pennsylvania's Lebanon County. Bayer's Myerstown site has a rich history dating back over 75 years, and it has now grown to become the largest manufacturing site in Bayer's Consumer Health network globally, producing brands such as Bayer® Aspirin, Aleve®, Claritin®, One A Day®, Alka-Seltzer Plus®, Midol®, and more. "Our trusted brands have been helping people live healthier lives for generations. The Myerstown annex will enable us to bring science-backed products to market with more speed and reliability than ever before," stated Dave Tomasi, President of Bayer's Consumer Health division in North America. "The expanded facility will further strengthen our commitment to providing safe, effective and high-quality self-care solutions that our consumers and customers can depend on." Bayer's Myerstown facility is set to advance its production capabilities through the integration of modernized technology and streamlined processes, strengthening its ability to reliably deliver science-driven self-care solutions. The new space is designed to move products more efficiently with eight new product packaging lines and automated systems in logistics. With the expansion, Bayer is increasing its ability to swiftly respond to the evolving needs of its consumers and customers. Bayer's commitment to growth extends beyond infrastructure and technology; it is an investment in the future of health and wellness for consumers across North America and the people of Myerstown. Along with expanding its physical footprint, the company is dedicated to digitally upskilling its workforce to ensure that employees and the local community are equipped with the knowledge needed to navigate the modern manufacturing landscape. Bayer also plans to welcome local high school educators to tour its Myerstown facilities and operations to bring back information and insights to their school districts. "We recognize that the key to sustainable growth lies in our people. That's why we will enable our workforce with the skills needed to adapt to new technologies so they can excel in their careers," said Divakar Amin, Vice President & Site Manager of Myerstown. "We are proud to contribute to the local economy and foster a vibrant workforce made up of many Myerstown locals. Together, we are building a brighter future for Bayer and the communities we serve." As Bayer continues to innovate and empower everyday health, the company remains steadfast in its mission to elevate the quality of life for people around the world through trusted health and nutrition solutions. "Our commitment to credible science and consumer advocacy drives our mission Health for all, Hunger for none," said Michael Sullivan, Senior Vice President of Product Supply for Bayer's Consumer Health division in North America. "We are excited about the positive impact this investment will have as we are paving the way for a healthier future where everyone has access to the products that they need to support their well-being." About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to View source version on Contacts Media Contact: Hannah SchwartzEmail: Cell: 862-783-8442
